phenytoin has been researched along with methimazole in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aizawa, T; Kawabe, T; Tsukui, T; Yamada, T | 1 |
| Bechar, M; Korczyn, AD | 1 |
| Dalton, C; Verebely, K | 1 |
| Pedersen, KO | 1 |
| Nicoloff, JT | 1 |
| Madappally, MW; Mehlman, MA; Ruegamer, WR; Tobin, RB | 1 |
| Zaninovich, AA | 1 |
1 review(s) available for phenytoin and methimazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for phenytoin and methimazole
| Article | Year |
|---|---|
Effects of oestrogens on thyroxine turnover in hyperthyroidism.
Topics: Adult; Estrogens; Female; Graves Disease; Humans; Hyperthyroidism; Injections, Intravenous; Iodine Isotopes; Male; Methimazole; Middle Aged; Phenols; Phenytoin; Placebos; Thyroid Gland; Thyroxine; Thyroxine-Binding Proteins | 1972 |
13 other study(ies) available for phenytoin and methimazole
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Studies on the mechanism of goitrogenic action of diphenylthiohydantoin.
Topics: Animals; Antithyroid Agents; Iodine; Male; Methimazole; Organ Size; Phenytoin; Propylthiouracil; Rats; Thyroid Gland; Thyroxine; Triiodothyronine | 1978 |
Convulsive fits in thyrotoxicosis.
Topics: Adult; Humans; Hyperthyroidism; Male; Methimazole; Phenytoin; Seizures | 1976 |
Hypotriglyceridemic activity of 5,5'-diphenyl-2-thiohydantoin (DPTH).
Topics: Animals; Antithyroid Agents; Lipids; Liver; Male; Methimazole; Methylthiouracil; Organ Size; Phenytoin; Phospholipids; Propylthiouracil; Rats; Rats, Inbred Strains; Thiouracil; Thyroid Gland; Triglycerides | 1972 |
A systematic study of variables affecting protein binding of thyroxine and triiodothyronine in serum.
Topics: Anions; Barbiturates; Buffers; Caffeine; Depression, Chemical; Dialysis; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Methimazole; Osmolar Concentration; Phenytoin; Protein Binding; Salicylates; Temperature; Theophylline; Thyroxine; Thyroxine-Binding Proteins; Time Factors; Triiodothyronine; Ultrafiltration | 1974 |
A new method for the measurement of acute alterations in thyroxine deiodination rate in man.
Topics: Adrenocorticotropic Hormone; Epinephrine; Humans; Hydrocortisone; Iodine; Iodine Radioisotopes; Methimazole; Methods; Oxytocin; Phenytoin; Potassium Iodide; Prednisolone; Propylthiouracil; Thyrotropin; Thyroxine; Triiodothyronine | 1970 |
Mode of action of 5,5'-diphenylthiohydantoin-sites of action of 5,5'-diphenylthiohydantoin in mitochondria in relationship to thyroxine-stimulated responses.
Topics: Animals; Binding Sites; Carbon Isotopes; Carboxy-Lyases; Carnitine; Diet; Dinitrophenols; Drug Interactions; Fructose-Bisphosphatase; Gluconeogenesis; Glucose-6-Phosphatase; Glycerophosphates; In Vitro Techniques; Ligases; Liver; Methimazole; Mitochondria, Liver; Oxygen Consumption; Phenytoin; Pyruvates; Rats; Succinates; Sulfides; Thyroxine | 1972 |